Cargando…

Hepatic PEMT Expression Decreases with Increasing NAFLD Severity

Choline deficiency causes hepatic fat accumulation, and is associated with a higher risk of nonalcoholic fatty liver disease (NAFLD) and more advanced NAFLD-related hepatic fibrosis. Reduced expression of hepatic phosphatidylethanolamine N-methyltransferase (PEMT), which catalyzes the production of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piras, Ignazio S., Raju, Anish, Don, Janith, Schork, Nicholas J., Gerhard, Glenn S., DiStefano, Johanna K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409182/ https://www.ncbi.nlm.nih.gov/pubmed/36012560 http://dx.doi.org/10.3390/ijms23169296

Ejemplares similares

Palmitate and Fructose Interact to Induce Human Hepatocytes to Produce Pro-Fibrotic Transcriptional Responses in Hepatic Stellate Cells Exposed to Conditioned Media
por: Piras, Ignazio S., et al.
Publicado: (2020)

NAFLD in normal weight individuals
por: DiStefano, Johanna K., et al.
Publicado: (2022)

AEBP1 expression increases with severity of fibrosis in NASH and is regulated by glucose, palmitate, and miR-372-3p
por: Gerhard, Glenn S., et al.
Publicado: (2019)

PEMT: a patent enrichment tool for drug discovery
por: Gadiya, Yojana, et al.
Publicado: (2022)

Pemt Deficiency Ameliorates Endoplasmic Reticulum Stress in Diabetic Nephropathy
por: Watanabe, Mayu, et al.
Publicado: (2014)

Alternative splicing of UCP1 by non-cell-autonomous action of PEMT
por: Johnson, Jordan M., et al.
Publicado: (2019)

Differentially methylated loci in NAFLD cirrhosis are associated with key signaling pathways
por: Gerhard, Glenn S., et al.
Publicado: (2018)

PEMT Mediates Hepatitis C Virus-Induced Steatosis, Explains Genotype-Specific Phenotypes and Supports Virus Replication
por: Abomughaid, Mosleh, et al.
Publicado: (2023)

Differential DNA methylation and changing cell-type proportions as fibrotic stage progresses in NAFLD
por: Johnson, Nicholas D., et al.
Publicado: (2021)

Differentially expressed mRNAs and lncRNAs shared between activated human hepatic stellate cells and nash fibrosis
por: Gerhard, Glenn S., et al.
Publicado: (2020)

Epigenetic repression of phosphatidylethanolamine N-methyltransferase (PEMT) in BRCA1-mutated breast cancer
por: Li, Da, et al.
Publicado: (2014)

The Role of Choline, Soy Isoflavones, and Probiotics as Adjuvant Treatments in the Prevention and Management of NAFLD in Postmenopausal Women
por: DiStefano, Johanna K.
Publicado: (2023)

PEMT rs7946 Polymorphism and Sex Modify the Effect of Adequate Dietary Choline Intake on the Risk of Hepatic Steatosis in Older Patients with Metabolic Disorders
por: Wu, Chien-Hsien, et al.
Publicado: (2023)

Relationship Between PEMT Gene rs7946 Polymorphism and Nutritional Choline Status in Association With Nonalcoholic Fatty Liver Risk
por: Wu, Chien Hsien, et al.
Publicado: (2022)

Cross-Species and Human Inter-Tissue Network Analysis of Genes Implicated in Longevity and Aging Reveal Strong Support for Nutrient Sensing
por: Podder, Avijit, et al.
Publicado: (2021)

The Role of Long Non-Coding RNAs (lncRNAs) in the Development and Progression of Fibrosis Associated with Nonalcoholic Fatty Liver Disease (NAFLD)
por: Hanson, Amanda, et al.
Publicado: (2018)

A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains
por: Wood, G. Craig, et al.
Publicado: (2017)

Risk of severe illness of COVID‐19 patients with NAFLD and increased NAFLD fibrosis scores
por: Yao, Renling, et al.
Publicado: (2021)

Single Nucleotide Polymorphisms in PEMT and MTHFR Genes are Associated with Omega 3 and 6 Fatty Acid Levels in the Red Blood Cells of Children with Obesity
por: Serafim, Vlad, et al.
Publicado: (2019)

Decreased PEDF Promotes Hepatic Fatty Acid Uptake and Lipid Droplet Formation in the Pathogenesis of NAFLD
por: Huang, Kuang-Tzu, et al.
Publicado: (2020)

Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy
por: Koralegedara, Iresha Sandamali, et al.
Publicado: (2022)

Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development
por: Kriss, Michael, et al.
Publicado: (2020)

Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis
por: Bernhardt, Philipp, et al.
Publicado: (2018)

Regular Exercise Is Associated with a Reduction in the Risk of NAFLD and Decreased Liver Enzymes in Individuals with NAFLD Independent of Obesity in Korean Adults
por: Bae, Ji Cheol, et al.
Publicado: (2012)

Acute exercise does not decrease liver fat in men with overweight or NAFLD
por: Bilet, L., et al.
Publicado: (2015)

Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD
por: Takahashi, Hirokazu, et al.
Publicado: (2021)

Plasma Levels of Homocysteine and Cysteine Increased in Pediatric NAFLD and Strongly Correlated with Severity of Liver Damage
por: Pastore, Anna, et al.
Publicado: (2014)

Identification of Novel Clinical Factors Associated with Hepatic Fat Accumulation in Extreme Obesity
por: Gerhard, Glenn S., et al.
Publicado: (2014)

Transcriptomic Profiling of Obesity-Related Nonalcoholic Steatohepatitis Reveals a Core Set of Fibrosis-Specific Genes
por: Gerhard, Glenn S, et al.
Publicado: (2018)

Editorial: The heart of NAFLD
por: Chew, Nicholas W. S., et al.
Publicado: (2023)

A Quantitative Systems Pharmacology Platform Reveals NAFLD Pathophysiological States and Targeting Strategies
por: Lefever, Daniel E., et al.
Publicado: (2022)

Contribution of Metabolomics to the Understanding of NAFLD and NASH Syndromes: A Systematic Review
por: Piras, Cristina, et al.
Publicado: (2021)

Hepatic Steatosis, Carbohydrate Intake, and Food Quotient in Patients with NAFLD
por: Gonzalez, Concepcion, et al.
Publicado: (2013)

Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD
por: Fourman, Lindsay T., et al.
Publicado: (2020)

Distinct Hepatic Gene‐Expression Patterns of NAFLD in Patients With Obesity
por: Subudhi, Sonu, et al.
Publicado: (2021)

Parenteral Nutrition Associated Hepatic Steatosis and NAFLD Intersect at AMPK
por: Guthrie, Gregory
Publicado: (2022)

Reply to: “Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD”
por: van Kleef, Laurens A., et al.
Publicado: (2022)

Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model
por: Niu, Shu, et al.
Publicado: (2022)

Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
por: Jeong, Seogsong, et al.
Publicado: (2023)

Exercise-Induced Irisin Decreases Inflammation and Improves NAFLD by Competitive Binding with MD2
por: Zhu, Weiwei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t3d39ikkede3sbm69oj9mm4bo9